The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Lymph Node Staging by Positron Emission Tomography in Patients With Carcinoma of the Cervix
Abstract
PURPOSE: The aim of this study was to compare the results of computed tomography (CT) and positron emission tomography (PET) with [18 F]-fluoro-2-deoxy-d-glucose (FDG) for lymph node staging in patients with carcinoma of the cervix and to evaluate the relationship of the imaging findings to prognosis. PATIENTS AND METHODS: We retrospectively compared the results of CT lymph node staging and whole-body FDG-PET in 101 consecutive patients with carcinoma of the cervix. Patients were treated with standard irradiation and chemotherapy (as clinically indicated) and observed at 3-month intervals for a median of 15.4 months (range, 2.5 to 30 months). Progression-free survival was evaluated by the Kaplan-Meier method. RESULTS: CT demonstrated abnormally enlarged pelvic lymph nodes in 20 (20%) and para-aortic lymph nodes in seven (7%) of the 101 patients. PET demonstrated abnormal FDG uptake in pelvic lymph nodes in 67 (67%), in para-aortic lymph nodes in 21 (21%), and in supraclavicular lymph node in eight (8%). The 2-year progression-free survival, based solely on para-aortic lymph node status, was 64% in CT-negative and PET-negative patients, 18% in CT-negative and PET-positive patients, and 14% in CT-positive and PET-positive patients (P < .0001). A multivariate analysis demonstrated that the most significant prognostic factor for progression-free survival was the presence of positive para-aortic lymph nodes as detected by PET imaging (P = .025). CONCLUSION: This study demonstrates that FDG-PET detects abnormal lymph node regions more often than does CT and that the findings on PET are a better predictor of survival than those of CT in patients with carcinoma of the cervix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Rose, P. G., Adler, L. P., Rodriguez, M., Faulhaber, P. F., Abdul-Karim, F. W., & Miraldi, F. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.41 · Cited by 345
Radiological Evaluation of Lymph Node Metastases in Patients With Cervical Cancer: A Meta-analysis
Scheidler, J. (1997) · JAMA · doi:10.1001/jama.1997.03550130070040 · Cited by 320
Heller, P. B., Malfetano, J. H., Bundy, B. N., Barnhill, D. R., & Okagaki, T. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90085-y · Cited by 194
Evaluation of FDG PET in patients with cervical cancer.
Sugawara, Y., Eisbruch, A., Kosuda, S., Recker, B. E., Kison, P. V., & Wahl, R. L. (1999) · PubMed · Cited by 181
Russell, A. H., Shingleton, H. M., Jones, W. B., Fremgen, A. M., M.D., D. P. W., Clive, R. E., & Chmiel, J. S. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0300 · Cited by 29
Cited by
Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12611 · Cited by 1,134
Waggoner, S. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13778-6 · Cited by 844
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Self-citationBermudez, A., Bhatla, N., & Leung, E. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.06.004 · Cited by 657
Integrated PET/CT: Current Applications and Future Directions
von Schulthess, G. K., Steinert, H. C., & Hany, T. F. (2006) · Radiology · doi:10.1148/radiol.2382041977 · Cited by 619
Metadata
- Authors
- Grigsby, P. W., Siegel, B. A., & Dehdashti, F.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-09-01
- Volume
- 19
- Issue
- 17
- Pages
- 3745-3749
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1755258021
- Cited by
- 471
- References
- 10
- FWCI
- 32.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.